Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:3457 |
Name | invasive lobular carcinoma |
Definition | A breast lobular carcinoma that is characterized by infiltration into the tissue of the breast outside of the lobule where it originated. |
Source | DiseaseOntology.org |
Alt Ids | |
Path | disease disease of cellular proliferation cancer organ system cancer thoracic cancer breast cancer breast carcinoma breast lobular carcinoma invasive lobular carcinoma |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02206984 | Phase I | Tamoxifen Anastrozole Fulvestrant | Endocrine Response in Women With Invasive Lobular Breast Cancer | Completed | USA | 0 |
NCT03356860 | Phase Ib/II | Cyclophosphamide + Durvalumab + Epirubicin + Paclitaxel Cyclophosphamide + Epirubicin + Paclitaxel | Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer. (B-IMMUNE) | Completed | BEL | 0 |
NCT03596073 | Phase I | Calcipotriene | Topical Calcipotriene Treatment for Breast Cancer Immunoprevention | Terminated | USA | 0 |
NCT04781725 | Phase II | INT230-6 | Intratumoral INT230-6 in Breast Cancer | Unknown status | CAN | 0 |
NCT06139107 | Phase I | Abemaciclib + Letrozole | RADIANT: Pre-op Radiation With Abemaciclib and Letrozole | Recruiting | USA | 0 |
NCT06607757 | Phase II | Fulvestrant Capivasertib + Fulvestrant | Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer | Not yet recruiting | DEU | 0 |